Immunogenicity
Date: | 13-Jun-16 to 14-Jun-16 |
Location: | Holiday Inn Kensington Forum / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
SMi is proud to announce the return of their 3rd annual Immunogenicity event to London in 2016!
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more!
KEY SESSIONS:
• MHRA: Towards harmonisation of immunogenicity assays
• Integration of immunogenicity risk data to forecast clinical outcomes
• A harmonised approach to interpretation and reporting of clinical immunogenicity data
• Development and validation of cell based antibody neutralisation assays
KEY SPEAKERS:
- Annie De Groot, CEO and CSO, EpiVax, Inc.
- Adnan Khan, Senior Scientist Immunology/Pharmacology, UCB
- Meenu Wadhwa, Section Leader, Cytokines and Growth Factors, NIBSC, MHRA
- Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
- Daniel Sikkema, Executive Director, Head of Immunogenicity and Clinical Immunology, GSK
- Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb
- Tim Hickling, Immunogenicity Sciences Discipline Lead, Pfizer
Plus two interactive post-conference workshops:
1) Approaches to standardising assays for measuring drug levels and anti drug antibodies to biotherapeutics in clinical practice (Led by Hishani Kirby Associates and GSK)
2) Unwanted immunogenicity from bench to bedside (Led by IPM Biotech and ImmunXperts)
Register by 31st March to save £400!
Register by 29th April to save £200!
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more!
KEY SESSIONS:
• MHRA: Towards harmonisation of immunogenicity assays
• Integration of immunogenicity risk data to forecast clinical outcomes
• A harmonised approach to interpretation and reporting of clinical immunogenicity data
• Development and validation of cell based antibody neutralisation assays
KEY SPEAKERS:
- Annie De Groot, CEO and CSO, EpiVax, Inc.
- Adnan Khan, Senior Scientist Immunology/Pharmacology, UCB
- Meenu Wadhwa, Section Leader, Cytokines and Growth Factors, NIBSC, MHRA
- Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
- Daniel Sikkema, Executive Director, Head of Immunogenicity and Clinical Immunology, GSK
- Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb
- Tim Hickling, Immunogenicity Sciences Discipline Lead, Pfizer
Plus two interactive post-conference workshops:
1) Approaches to standardising assays for measuring drug levels and anti drug antibodies to biotherapeutics in clinical practice (Led by Hishani Kirby Associates and GSK)
2) Unwanted immunogenicity from bench to bedside (Led by IPM Biotech and ImmunXperts)
Register by 31st March to save £400!
Register by 29th April to save £200!
Exhibitors
EpiVax, UCB, MHRA, Selecta Biosciences, GSK, Bristol-Mayers Squibb, Pfizer, Janssen, ProImmune, ISA Pharmaceuticals,
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today